e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diffuse parenchymal lung disease II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial lung disease; where do we stand without histopathology?
N. Gupta, R. Gupta, N. Singh, R. Dixit, S. Jangir (Ajmer, India)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease II
Session:
Diffuse parenchymal lung disease II
Session type:
Thematic Poster Session
Number:
2369
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Gupta, R. Gupta, N. Singh, R. Dixit, S. Jangir (Ajmer, India). Interstitial lung disease; where do we stand without histopathology?. Eur Respir J 2013; 42: Suppl. 57, 2369
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019
Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018
Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014
Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019
Interstitial lung disease
Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea
Year: 2015
Interstitial lung disease
Source: ERS Course 2015
Year: 2015
Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014
Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012
"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Debate – Controversies in interstitial lung disease
Source: ERS webinar 2021
Access for REGISTERED non-members
Year: 2021
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012
Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept